Generic medicines in Switzerland are more expensive than 53% than abroad. This is indicated by Santésuisse
Taking as a basis a franc/euro exchange rate of 1.07 (the same applied by the Confederation), last September generic medicines were more expensive in Switzerland than the 53% than abroad.
This is indicated by a joint note by Santésuisse (an organization of health insurers) and the Interpharma association (which brings together pharmaceutical companies that practice research).
The international comparison - the eighth - carried out by these two bodies also shows that the price level of patent-protected medicines was 14% higher than that of the nine reference countries taken into consideration by the Federal Office of Public Health (Belgium , Denmark, Germany, Finland, France, Great Britain, the Netherlands, Austria and Sweden).
The original off-patent drugs were more expensive than 20% than the peer country average.
Related news: Auslandpreisvergleich Medikamente: 14% Preisdifferenz bei patentgeschützten Medikamenten, 53% Preisunterschied bei Generika
